Home › Funds › Campbell & CO Investment Adviser LLC › REGN

Campbell & CO Investment Adviser LLC position in REGN

REGENERON PHARMACEUTICALS · Health Care

Campbell & CO Investment Adviser LLC reported holding 9,899 shares of REGN (REGENERON PHARMACEUTICALS) in its Q2 2026 13F filing — a position valued at US$6.2M, representing 0.32% of its reported portfolio and ranking #43 among its reported holdings. Campbell & CO Investment Adviser LLC has disclosed REGN holdings in 4 of the last 8 reported quarters, going back to Q3 2024.

Latest position (Q2 2026)9.90K sh
Reported value held$6.17M
Portfolio Weight0.32%
First reportedQ3 2024
Last changeNew
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Campbell & CO Investment Adviser LLC's REGN position evolved

Campbell & CO Investment Adviser LLC first disclosed a stake in REGN in Q3 2024 at 4,171 shares (US$4.4M). The position peaked in Q2 2026 at 9,899 shares, worth US$6.2M. Across 4 filings, Campbell & CO Investment Adviser LLC increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 9,899 shares valued at US$6.2M. Notable position changes include a 65% increase in Q4 2024 (shares fell 11% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2024 4.17K $4.38M New
Q4 2024 6.88K $4.90M Add
Q2 2025 1.34K $706.12K New
Q2 2026 9.90K $6.17M New

Dots on the line are colored by change type; missing quarters mean no position was reported.

About REGN and 13F data

REGN (REGENERON PHARMACEUTICALS) is a Health Care company. 31 other funds we track also report a position in REGN — the largest reported positions include Dodge & Cox (US$3.04B), DODGE & COX (US$3.04B), LOOMIS SAYLES & CO L P (US$1.16B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding REGN

All REGN fund holders →

FAQ

How long has Campbell & CO Investment Adviser LLC held REGN?

Campbell & CO Investment Adviser LLC has disclosed REGN holdings in 4 of the last 8 reported quarters, going back to Q3 2024.

What is Campbell & CO Investment Adviser LLC's current position in REGN?

As of Q2 2026, Campbell & CO Investment Adviser LLC holds 9.90K shares of REGN (REGENERON PHARMACEUTICALS), valued at $6.17M, representing 0.32% of its reported portfolio and ranking #43.

Has Campbell & CO Investment Adviser LLC been buying or selling REGN?

In the latest 13F filing (Q2 2026), Campbell & CO Investment Adviser LLC newly opened its position in REGN. The position peaked in Q2 2026 at 9.90K shares.

Which other funds hold REGN?

Other major institutional holders of REGN include Dodge & Cox, DODGE & COX, LOOMIS SAYLES & CO L P, among 31 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.